Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.980
+0.080 (1.63%)
At close: Apr 1, 2026, 4:00 PM EDT
4.920
-0.060 (-1.20%)
After-hours: Apr 1, 2026, 6:38 PM EDT

Candel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3653104064352224
Market Cap Growth
-12.54%-23.66%850.14%-17.39%-76.93%-
Enterprise Value
294.07239.03306.6720.714.04142.27
Last Close Price
4.985.658.681.471.797.82
PE Ratio
--7.85-4.99-1.12-2.75-4.09
PS Ratio
----414.131794.84
PB Ratio
5.275.976.133.361.083.50
P/TBV Ratio
5.185.764.143.341.082.30
P/FCF Ratio
--7.97-15.03-1.23-1.58-9.33
P/OCF Ratio
--8.10-15.04-1.25-1.65-10.10
EV/Sales Ratio
----32.361138.18
EV/EBITDA Ratio
--5.04-9.47-0.55-0.12-5.58
EV/EBIT Ratio
--4.95-9.19-0.54-0.12-5.53
EV/FCF Ratio
--6.15-11.34-0.60-0.12-5.91
Debt / Equity Ratio
0.940.940.051.050.470.01
Debt / EBITDA Ratio
-1.03-1.03-0.42-0.61-0.67-0.02
Debt / FCF Ratio
-1.26-1.26-0.50-0.66-0.70-0.02
Net Debt / Equity Ratio
-1.36-1.36-1.34-0.99-0.99-1.28
Net Debt / EBITDA Ratio
1.491.492.750.341.393.22
Net Debt / FCF Ratio
1.821.823.300.371.443.41
Asset Turnover
-0000.000.00
Quick Ratio
13.3113.312.742.5012.4815.41
Current Ratio
13.4913.492.772.5912.8115.84
Return on Equity (ROE)
-64.58%-64.58%-139.56%-125.50%-33.61%-178.06%
Return on Assets (ROA)
-41.60%-41.60%-45.08%-64.58%-41.61%-40.36%
Return on Invested Capital (ROIC)
2333.38%2333.38%52142.19%-2168.98%-1708.34%-7339.80%
Return on Capital Employed (ROCE)
-52.03%-52.03%-69.27%-77.48%-44.54%-43.82%
Earnings Yield
-10.47%-12.74%-20.05%-89.12%-36.31%-24.42%
FCF Yield
-10.66%-12.54%-6.65%-81.15%-63.20%-10.72%
Buyback Yield / Dilution
-67.19%-67.19%-9.47%-0.39%-52.72%-62.49%
Total Shareholder Return
-67.19%-67.19%-9.47%-0.39%-52.72%-62.49%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q